Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease

• DOI: 10.1034/j.1600-0404.107.s179.7.x
• Publication Date: 2003-03-11T02:30:53Z
• Authors: Eva Arnáiz; Ove Almkvist
• Keywords: Neuropsychological Assessment; Etiology

Recent research has identified a transitional state between the cognitive changes of normal aging and Alzheimer's disease (AD), known as mild impairment (MCI). MCI patients experience memory loss to greater extent than one would expect for age, yet they do not meet currently accepted criteria clinically probable AD. An issue under investigation is whether represents preclinical stages AD or distinct static aetiology. In an attempt address this issue, present investigations are adopting convergent approach detection AD, where multiple risk factors considered when making diagnosis. Currently, most important tools assessing early neuropsychological evaluation. subjects typically record performance that healthy older individuals demented patients. Tests new learning, delayed recall attention/executive function seem provide valuable information screening diagnosis if interpreted properly. Recommendations concerning methodological issues management studies were made.